Pediatrics Strabismus News

Healio’s top items from this year’s American Academy of Ophthalmology meeting included pearls for navigating secondary dry eye disease as well as data for low-dose atropine as a myopia treatment in children aged 3 to 17 years.

SAN FRANCISCO — In this Healio Video Perspective from Eyecelerator@AAO, Nick Ruth, MBA, of Sydnexis previews upcoming data for a progressive myopia treatment for pediatric patients.

SAN FRANCISCO — In this Healio Video Perspective from the AAO meeting, Rupa Wong, MD, discusses the Luminopia binocular therapy headset for children with amblyopia.

SAN FRANCISCO — A low-dose, preservative-free formulation of atropine is effective in slowing myopia progression in children aged 3 to 17 years, according to phase 3 data presented here.

NEW YORK — In this Healio Video Perspective from OSN New York’s Disruptive Innovations Symposium, Nick Ruth of Sydnexis provides an update on a progressive myopia treatment for pediatric patients that is in development.

NEW ORLEANS — Objectively measured accommodative amplitude increased throughout the day in children using low-dose atropine for myopia management, according a study presented at Academy ’23.

This issue’s roundtable from our pediatric ophthalmology colleagues covers two important topics: amblyopia therapy and progressive myopia treatment. Our first challenge is to diagnose these two conditions at an early age.

According to a 2016 analysis of 145 studies including 2.1 million participants, myopia will affect nearly 50% of the global population by 2050.

A study of 40 patients recently published in Cureus suggested that SARS-CoV-2 may be transmissible via ocular routes.

An intervention undertaken by dozens of health centers reduced antibiotic use for pediatric conjunctivitis by up to 19% without increasing treatment failure, according to study findings.